Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Oxygenation with high-flow nasal cannula with 100% oxygen have now been evaluated in a number of studies and the data are convincing. The THRIVE technique is able to oxygenate patients safely and vital parameters has been shown to be stable. But it is of great importance to evaluate this new concept regarding other potential negative physiological aspects such as biological stress response detected by blood-bourne biomarkers before implementing it into clinical practice.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Apnoeic oxygenation using THRIVE | Experimental | Oxygenation by apnoea oxygenation using THRIVE |
|
| Endotracheal intubation and mechanical ventilation | Active Comparator | Ventilation and oxygenation by an endotracheal tub and mechanical ventilation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Apnoeic oxygenation using THRIVE | Device | Apnoeic oxygenation using THRIVE |
|
| Measure | Description | Time Frame |
|---|---|---|
| Oxidative stress | Biomarkers of oxidative stress such as Thiobarbituric acid reactive substances, Advanced Oxidation Protein Products,Reactive oxygen species and total antioxidant capacity in blood samples | Up to 2 hours after start of intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Biomarkers of neuronal injury | Biomarkers of neuronal injury and stress in blood such as S100 and Nuclear Serum Enolase | Up to 2 hours after start of intervention |
| Biomarkers of cardiac damage |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Karolinska University Hospital | Stockholm | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007442 | Intubation, Intratracheal |
| D012121 | Respiration, Artificial |
| ID | Term |
|---|---|
| D058109 | Airway Management |
| D013812 | Therapeutics |
| D007440 | Intubation |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Endotracheal intubation and mechanical ventilation | Device | Endotracheal intubation and mechanical ventilation |
|
Biomarkers of cardiac damage in blood such as troponin and ProBNP
| Up to 2 hours after start of intervention |
| Biomarkers of kidney injury | Biomarkers of kidney injury in blood such as creatinine | Up to 2 hours after start of intervention |
| Markers of RNA damage | Markers of RNA damage in blood | Up to 2 hours after start of intervention |
| Inflammatory response | Biomarkers of Inflammatory response in blood such as cytokines and interleukins | Up to 2 hours after start of intervention |
| D012151 |
| Resuscitation |
| D004638 | Emergency Treatment |
| D012138 | Respiratory Therapy |